Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Melanoma

Free Subscription Articles published in J Invest Dermatol Retrieve available abstracts of 85 articles: HTML format

Single Articles

May 2008
1. LACHIEWICZ AM , Berwick M, Wiggins CL, Thomas NE, et al
   Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program.
   J Invest Dermatol. 2008;128:1340-2.
   PubMed     Related articles       Free Full Text
   
   
   April 2008
2. LIPKIN G
   Plasticity of the Cancer Cell: Implications for Epigenetic Control of Melanoma and Other Malignancies.
   J Invest Dermatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. TAO J , Li Y, Liu YQ, Wang L, et al
   Restoration of the Expression of Transports Associated with Antigen Processing in Human Malignant Melanoma Increases Tumor-Specific Immunity.
   J Invest Dermatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. ROMAGOSA Y , Hu S, Kirsner RS
   Chronic diseases and non-melanoma skin cancer: is there an association?
   J Invest Dermatol. 2008;128:768.
   PubMed     Related articles       Free Full Text
   
   
   March 2008
5. NAJAR HM , Dutz JP
   Topical CpG Enhances the Response of Murine Malignant Melanoma to Dacarbazine.
   J Invest Dermatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. QUINTANILLA-DIECK MJ , Codriansky K, Keady M, Bhawan J, et al
   Cathepsin K in Melanoma Invasion.
   J Invest Dermatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. FARGNOLI MC , Pike K, Pfeiffer RM, Tsang S, et al
   MC1R Variants Increase Risk of Melanomas Harboring BRAF Mutations.
   J Invest Dermatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. FLORELL SR , Meyer LJ, Boucher KM, Grossman D, et al
   Increased Melanocytic Nevi and Nevus Density in a G-34T CDKN2A/p16 Melanoma-Prone Pedigree.
   J Invest Dermatol. 2008;.
   PubMed     Related articles   
   
   
   
9. HOUBEN R , Vetter-Kauczok CS, Ortmann S, Rapp UR, et al
   Phospho-ERK Staining Is a Poor Indicator of the Mutational Status of BRAF and NRAS in Human Melanoma.
   J Invest Dermatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. NORTH JP , Kageshita T, Pinkel D, Leboit PE, et al
    Distribution and Significance of Occult Intraepidermal Tumor Cells Surrounding Primary Melanoma.
    J Invest Dermatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. LASITHIOTAKIS KG , Sinnberg TW, Schittek B, Flaherty KT, et al
    Combined Inhibition of MAPK and mTOR Signaling Inhibits Growth, Induces Cell Death, and Abrogates Invasive Growth of Melanoma Cells.
    J Invest Dermatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
12. TRUZZI F , Marconi A, Lotti R, Dallaglio K, et al
    Neurotrophins and Their Receptors Stimulate Melanoma Cell Proliferation and Migration.
    J Invest Dermatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. WANG W , Edington HD, Rao UN, Jukic DM, et al
    STAT3 as a Biomarker of Progression in Atypical Nevi of Patients with Melanoma: Dose-Response Effects of Systemic IFNalpha Therapy.
    J Invest Dermatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. OLDENBURG RP , Liu MS, Kolodney MS
    Selective amplification of rare mutations using locked nucleic acid oligonucleotides that competitively inhibit primer binding to wild-type DNA.
    J Invest Dermatol. 2008;128:398-402.
    PubMed     Related articles    Abstract available
    
    
    January 2008
15. MURAKAMI T , Sato A, Chun NA, Hara M, et al
    Transcriptional Modulation Using HDACi Depsipeptide Promotes Immune Cell-Mediated Tumor Destruction of Murine B16 Melanoma.
    J Invest Dermatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. RAJPARA V , Hu S, Kirsner RS
    The role of Gadd45a in the survival of melanocytes and melanoma cells.
    J Invest Dermatol. 2008;128:4.
    PubMed     Related articles       Free Full Text
    
    
    
17. WATABE H , Valencia JC, Le Pape E, Yamaguchi Y, et al
    Involvement of dynein and spectrin with early melanosome transport and melanosomal protein trafficking.
    J Invest Dermatol. 2008;128:162-74.
    PubMed     Related articles    Abstract available
    
    
    
18. KAWAKAMI A , Sakane F, Imai S, Yasuda S, et al
    Rab7 regulates maturation of melanosomal matrix protein gp100/Pmel17/Silv.
    J Invest Dermatol. 2008;128:143-50.
    PubMed     Related articles    Abstract available
    
    
    December 2007
19. HILMI C , Larribere L, Giuliano S, Bille K, et al
    IGF1 Promotes Resistance to Apoptosis in Melanoma Cells through an Increased Expression of BCL2, BCL-X(L), and Survivin.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
20. LI C , Chen K, Liu Z, Wang LE, et al
    Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, Contribute to Risk of Cutaneous Melanoma.
    J Invest Dermatol. 2007;.
    PubMed     Related articles   
    
    
    
21. SHELLMAN YG , Howe WR, Miller LA, Goldstein NB, et al
    Hyperthermia Induces Endoplasmic Reticulum-Mediated Apoptosis in Melanoma and Non-Melanoma Skin Cancer Cells.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. PAOLI J , Smedh M, Wennberg AM, Ericson MB, et al
    Multiphoton Laser Scanning Microscopy on Non-Melanoma Skin Cancer: Morphologic Features for Future Non-Invasive Diagnostics.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. FUKUNAGA-KALABIS M , Herlyn M
    Unraveling mysteries of the multifunctional protein SPARC.
    J Invest Dermatol. 2007;127:2497-8.
    PubMed     Related articles    Abstract available
    
    
    
24. CAGNANO E , Hershkovitz O, Zilka A, Bar-Ilan A, et al
    Expression of Ligands to NKp46 in Benign and Malignant Melanocytes.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
25. HOFFMANN D , Bayer W, Heim A, Potthoff A, et al
    Evaluation of Twenty-One Human Adenovirus Types and One Infectivity-Enhanced Adenovirus for the Treatment of Malignant Melanoma.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. COLONE M , Calcabrini A, Toccacieli L, Bozzuto G, et al
    The Multidrug Transporter P-Glycoprotein: A Mediator of Melanoma Invasion?
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. RUDRABHATLA SR , Petroll WM, Mahaffey CL, Mummert ME, et al
    Development of a Hyaluronan Targeted Contrast Reagent for the Demarcation of Melanoma Margins In Vivo.
    J Invest Dermatol. 2007;.
    PubMed     Related articles   
    
    
    
28. KARBOWNICZEK M , Spittle CS, Morrison T, Wu H, et al
    mTOR Is Activated in the Majority of Malignant Melanomas.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
29. JENSEN AO , Olesen AB, Dethlefsen C, Sorensen HT, et al
    Chronic Diseases Requiring Hospitalization and Risk of Non-Melanoma Skin Cancers-A Population Based Study from Denmark.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
30. DE PANFILIS G , Campanini N, Santini M, Mori G, et al
    Phase- and Stage-Related Proportions of T Cells Bearing the Transcription Factor FOXP3 Infiltrate Primary Melanoma.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
31. CURTIN JA , Pinkel D, Bastian BC
    Absence of PDGFRA Mutations in Primary Melanoma.
    J Invest Dermatol. 2007;.
    PubMed     Related articles   
    
    
    
32. LACHIEWICZ AM , Berwick M, Wiggins CL, Thomas NE, et al
    Epidemiologic Support for Melanoma Heterogeneity Using the Surveillance, Epidemiology, and End Results Program.
    J Invest Dermatol. 2007;.
    PubMed     Related articles   
    
    
    
33. ASHTON-PROLLA P , Bakos L, Junqueira G Jr, Giugliani R, et al
    Clinical and Molecular Characterization of Patients at Risk for Hereditary Melanoma in Southern Brazil.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. FAYOLLE C , Pourchet J, de Fromentel CC, Puisieux A, et al
    Gadd45a Activation Protects Melanoma Cells from Ultraviolet B-Induced Apoptosis.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. HU WP , Wang JJ, Yu CL, Lan CC, et al
    Helium-neon laser irradiation stimulates cell proliferation through photostimulatory effects in mitochondria.
    J Invest Dermatol. 2007;127:2048-57.
    PubMed     Related articles    Abstract available
    
    
    
36. MCNEILL MS , Paulsen J, Bonde G, Burnight E, et al
    Cell death of melanophores in zebrafish trpm7 mutant embryos depends on melanin synthesis.
    J Invest Dermatol. 2007;127:2020-30.
    PubMed     Related articles    Abstract available
    
    
    July 2007
37. PELLACANI G , Guitera P, Longo C, Avramidis M, et al
    The Impact of In Vivo Reflectance Confocal Microscopy for the Diagnostic Accuracy of Melanoma and Equivocal Melanocytic Lesions.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. DAI DL , Wang Y, Liu M, Martinka M, et al
    Bim Expression Is Reduced in Human Cutaneous Melanomas.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. OKA M , Kikkawa U, Nishigori C
    Protein Kinase C-betaII Represses Hepatocyte Growth Factor-Induced Invasion by Preventing the Association of Adapter Protein Gab1 and Phosphatidylinositol 3-Kinase in Melanoma Cells.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. PRADA F , Benedetti LG, Bravo AI, Alvarez MJ, et al
    SPARC Endogenous Level, rather than Fibroblast-Produced SPARC or Stroma Reorganization Induced by SPARC, Is Responsible for Melanoma Cell Growth.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. SEIFERT M , Scherer SJ, Edelmann W, Bohm M, et al
    The DNA-Mismatch Repair Enzyme hMSH2 Modulates UV-B-Induced Cell Cycle Arrest and Apoptosis in Melanoma Cells.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
42. KAUFMANN WK , Nevis KR, Qu P, Ibrahim JG, et al
    Defective Cell Cycle Checkpoint Functions in Melanoma Are Associated with Altered Patterns of Gene Expression.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
43. MIRMOHAMMADSADEGH A , Mota R, Gustrau A, Hassan M, et al
    ERK1/2 Is Highly Phosphorylated in Melanoma Metastases and Protects Melanoma Cells from Cisplatin-Mediated Apoptosis.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. THALLINGER C , Werzowa J, Poeppl W, Kovar FM, et al
    Comparison of a Treatment Strategy Combining CCI-779 Plus DTIC Versus DTIC Monotreatment in Human Melanoma in SCID Mice.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. SCHMITT CJ , Franke WW, Goerdt S, Falkowska-Hansen B, et al
    Homo- and Heterotypic Cell Contacts in Malignant Melanoma Cells and Desmoglein 2 as a Novel Solitary Surface Glycoprotein.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. MATHIEU V , Le Mercier M, De Neve N, Sauvage S, et al
    Galectin-1 Knockdown Increases Sensitivity to Temozolomide in a B16F10 Mouse Metastatic Melanoma Model.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
47. GAZZANIGA S , Bravo AI, Guglielmotti A, van Rooijen N, et al
    Targeting Tumor-Associated Macrophages and Inhibition of MCP-1 Reduce Angiogenesis and Tumor Growth in a Human Melanoma Xenograft.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. GAREAU DS , Merlino G, Corless C, Kulesz-Martin M, et al
    Noninvasive Imaging of Melanoma with Reflectance Mode Confocal Scanning Laser Microscopy in a Murine Model.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. BERRAHMOUNE H , Herbeth B, Lamont JV, Masson C, et al
    Lack of association between EGF 61A>G polymorphism and plasma EGF concentration in the STANISLAS family study.
    J Invest Dermatol. 2007;127:969-70.
    PubMed     Related articles   
    
    
    March 2007
50. REDONDO P , Del Olmo J, Lopez-Diaz de Cerio A, Inoges S, et al
    Imiquimod Enhances the Systemic Immunity Attained by Local Cryosurgery Destruction of Melanoma Lesions.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. MEYER S , Orso E, Schmitz G, Landthaler M, et al
    Lubrol-RAFTs in Melanoma Cells: A Molecular Platform for Tumor-Promoting Ephrin-B2-Integrin-beta1 Interaction.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. BISHOP JA , Taylor T, Potts HW, Elliott F, et al
    Sun-Protective Behaviors in Families at Increased Risk of Melanoma.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
53. ERLANDSON A , Appelqvist F, Wennberg AM, Holm J, et al
    Novel CDKN2A Mutations Detected in Western Swedish Families with Hereditary Malignant Melanoma.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. ORLOW I , Begg CB, Cotignola J, Roy P, et al
    CDKN2A Germline Mutations in Individuals with Cutaneous Malignant Melanoma.
    J Invest Dermatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. RALLAN D , Bush NL, Bamber JC, Harland CC, et al
    Quantitative discrimination of pigmented lesions using three-dimensional high-resolution ultrasound reflex transmission imaging.
    J Invest Dermatol. 2007;127:189-95.
    PubMed     Related articles    Abstract available
    
    
    December 2006
56. LIU W , Kelly JW, Trivett M, Murray WK, et al
    Distinct Clinical and Pathological Features Are Associated with the BRAF(T1799A(V600E)) Mutation in Primary Melanoma.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
57. KATO M , Ohgami N, Kawamoto Y, Tsuzuki T, et al
    Protective Effect of Hyperpigmented Skin on UV-Mediated Cutaneous Cancer Development.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
58. WIENER Z , Kohalmi B, Pocza P, Jeager J, et al
    TIM-3 Is Expressed in Melanoma Cells and Is Upregulated in TGF-Beta Stimulated Mast Cells.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
59. LE GAL FA , Widmer VM, Dutoit V, Rubio-Godoy V, et al
    Tissue Homing and Persistence of Defined Antigen-Specific CD8(+) Tumor-Reactive T-Cell Clones in Long-Term Melanoma Survivors.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
60. LI C , Liu Z, Zhang Z, Strom SS, et al
    Genetic Variants of the Vitamin D Receptor Gene Alter Risk of Cutaneous Melanoma.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
61. GAGGIOLI C , Robert G, Bertolotto C, Bailet O, et al
    Tumor-Derived Fibronectin Is Involved in Melanoma Cell Invasion and Regulated by V600E B-Raf Signaling Pathway.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
62. BERWICK M
    Pathways to the development of melanoma: a complex issue.
    J Invest Dermatol. 2006;126:1932-3.
    PubMed     Related articles    Abstract available
    
    
    August 2006
63. TELLEZ CS , Davis DW, Prieto VG, Gershenwald JE, et al
    Quantitative Analysis of Melanocytic Tissue Array Reveals Inverse Correlation between Activator Protein-2alpha and Protease-Activated Receptor-1 Expression during Melanoma Progression.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
64. GYORFFY B , Lage H
    A Web-Based Data Warehouse on Gene Expression in Human Malignant Melanoma.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
65. BOASBERG PD , Hoon DS, Piro LD, Martin MA, et al
    Enhanced Survival Associated with Vitiligo Expression during Maintenance Biotherapy for Metastatic Melanoma.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
66. LARSON AA , Leachman SA, Eliason MJ, Cannon-Albright LA, et al
    Population-Based Assessment of Non-Melanoma Cancer Risk in Relatives of Cutaneous Melanoma Probands.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
67. YANG G , Zhang G, Pittelkow MR, Ramoni M, et al
    Expression Profiling of UVB Response in Melanocytes Identifies a Set of p53-Target Genes.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
68. THOMAS NE , Berwick M, Cordeiro-Stone M
    Could BRAF Mutations in Melanocytic Lesions Arise from DNA Damage Induced by Ultraviolet Radiation?
    J Invest Dermatol. 2006;126:1693-6.
    PubMed     Related articles    Abstract available
    
    
    
69. REES J
    Plenty new under the sun.
    J Invest Dermatol. 2006;126:1691-2.
    PubMed     Related articles    Abstract available
    
    
    July 2006
70. TADA Y , Riedl E, Lowenthal MS, Liotta LA, et al
    Identification and characterization of endogenous Langerin ligands in murine extracellular matrix.
    J Invest Dermatol. 2006;126:1549-58.
    PubMed     Related articles    Abstract available
    
    
    June 2006
71. LEVERKUS M , Gollnick H
    "Bak (and Bax) to the Future" - of Primary Melanoma Prognosis?
    J Invest Dermatol. 2006;126:1212-4.
    PubMed     Related articles    Abstract available
    
    
    
72. MIRMOHAMMADSADEGH A , Hassan M, Bardenheuer W, Marini A, et al
    STAT5 Phosphorylation in Malignant Melanoma Is Important for Survival and Is Mediated Through SRC and JAK1 Kinases.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
73. GRICHNIK JM
    Genomic instability and tumor stem cells.
    J Invest Dermatol. 2006;126:1214-6.
    PubMed     Related articles    Abstract available
    
    
    
74. RUDRABHATLA SR , Mahaffey CL, Mummert ME
    Tumor microenvironment modulates hyaluronan expression: the lactate effect.
    J Invest Dermatol. 2006;126:1378-87.
    PubMed     Related articles    Abstract available
    
    
    May 2006
75. OKAMOTO I , Roka F, Krogler J, Endler G, et al
    The EGF A61G Polymorphism Is Associated with Disease-Free Period and Survival in Malignant Melanoma.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
76. CHABBERT-DE PONNAT I , Buffard V, Leroy K, Bagot M, et al
    Antiproliferative Effect of Semaphorin 3F on Human Melanoma Cell Lines.
    J Invest Dermatol. 2006;.
    PubMed     Related articles   
    
    
    
77. DEBRET R , Le Naour RR, Sallenave JM, Deshorgue A, et al
    Elastin Fragments Induce IL-1beta Upregulation via NF-kappaB Pathway in Melanoma Cells.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    April 2006
78. ROESCH A , Becker B, Schneider-Brachert W, Hagen I, et al
    Re-Expression of the Retinoblastoma-Binding Protein 2-Homolog 1 Reveals Tumor-Suppressive Functions in Highly Metastatic Melanoma Cells.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
79. RANDI G , Naldi L, Gallus S, Landro AD, et al
    Number of Nevi at a Specific Anatomical Site and Its Relation to Cutaneous Malignant Melanoma.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
80. SCHAFER T , Merkl J, Klemm E, Wichmann HE, et al
    The Epidemiology of Nevi and Signs of Skin Aging in the Adult General Population: Results of the KORA-Survey 2000.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
81. SPICA T , Portela M, Gerard B, Formicone F, et al
    The A148T Variant of the CDKN2A Gene Is Not Associated with Melanoma Risk in the French and Italian Populations.
    J Invest Dermatol. 2006;.
    PubMed     Related articles   
    
    
    
82. CURTIN JA , Stark MS, Pinkel D, Hayward NK, et al
    PI3-Kinase Subunits Are Infrequent Somatic Targets in Melanoma.
    J Invest Dermatol. 2006;.
    PubMed     Related articles   
    
    
    
83. STRATIGOS AJ , Dimisianos G, Nikolaou V, Poulou M, et al
    Melanocortin Receptor-1 Gene Polymorphisms and the Risk of Cutaneous Melanoma in a Low-Risk Southern European Population.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    February 2006
84. CLARK RA , Chong BF, Mirchandani N, Yamanaka KI, et al
    A Novel Method for the Isolation of Skin Resident T Cells from Normal and Diseased Human Skin.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    January 2006
85. ALEXEEV V , Yoon K
    Distinctive Role of the cKit Receptor Tyrosine Kinase Signaling in Mammalian Melanocytes.
    J Invest Dermatol. 2006;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: